These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3219604

  • 1. Pressor responses to amastatin, bestatin and Plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran.
    Batt CM, Klein EW, Harding JW, Wright JW.
    Brain Res Bull; 1988 Nov; 21(5):731-5. PubMed ID: 3219604
    [Abstract] [Full Text] [Related]

  • 2. Increased blood pressure induced by central application of aminopeptidase inhibitors is angiotensinergic-dependent in normotensive and hypertensive rat strains.
    Jensen LL, Harding JW, Wright JW.
    Brain Res; 1989 Jun 19; 490(1):48-55. PubMed ID: 2758329
    [Abstract] [Full Text] [Related]

  • 3. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
    Wright JW, Roberts KA, Cook VI, Murray CE, Sardinia MF, Harding JW.
    Brain Res; 1990 Apr 23; 514(1):5-10. PubMed ID: 2357530
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of aminopeptidase inhibitors on angiotensin-induced pressor responses.
    Sullivan MJ, Harding JW, Wright JW.
    Brain Res; 1988 Jul 26; 456(2):249-53. PubMed ID: 3208081
    [Abstract] [Full Text] [Related]

  • 5. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
    Abhold RH, Sullivan MJ, Wright JW, Harding JW.
    J Pharmacol Exp Ther; 1987 Sep 26; 242(3):957-62. PubMed ID: 3656120
    [Abstract] [Full Text] [Related]

  • 6. Intracerebroventricularly applied peptidase inhibitors increase endogenous angiotensin levels.
    Batt CM, Jensen LL, Hanesworth JM, Harding JW, Wright JW.
    Brain Res; 1990 Oct 08; 529(1-2):126-30. PubMed ID: 2282487
    [Abstract] [Full Text] [Related]

  • 7. Amastatin and bestatin-induced dipsogenicity in the Sprague-Dawley rat.
    Quirk WS, Harding JW, Wright JW.
    Brain Res Bull; 1987 Jul 08; 19(1):145-7. PubMed ID: 3651838
    [Abstract] [Full Text] [Related]

  • 8. The effects of the aminopeptidase inhibitors amastatin and bestatin on angiotensin-evoked neuronal activity in rat brain.
    Harding JW, Felix D.
    Brain Res; 1987 Oct 27; 424(2):299-304. PubMed ID: 3676828
    [Abstract] [Full Text] [Related]

  • 9. Effects of aminopeptidase inhibition on the half-lives of [125I]angiotensins in the cerebroventricles of the rat.
    Dewey AL, Wright JW, Hanesworth JM, Harding JW.
    Brain Res; 1988 May 17; 448(2):369-72. PubMed ID: 3378160
    [Abstract] [Full Text] [Related]

  • 10. Central effects of a specific angiotensin receptor antagonist, sarthran (Sar1, Thr8AII) in normotensive and spontaneously hypertensive rat strains.
    Jensen LL, Harding JW, Wright JW.
    Brain Res; 1988 May 17; 448(2):359-63. PubMed ID: 3378158
    [Abstract] [Full Text] [Related]

  • 11. Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta.
    Robertson MJ, Cunoosamy MP, Clark KL.
    Br J Pharmacol; 1992 May 17; 106(1):166-72. PubMed ID: 1354540
    [Abstract] [Full Text] [Related]

  • 12. Influence of aminopeptidase inhibitors on brain angiotensin metabolism and drinking in rats.
    Wright JW, Quirk WS, Hanesworth JM, Harding JW.
    Brain Res; 1988 Feb 16; 441(1-2):215-20. PubMed ID: 3359232
    [Abstract] [Full Text] [Related]

  • 13. Effect of inhibition of central angiotensin pressor mechanisms on blood pressure in spontaneously hypertensive rats.
    Bruner CA, Kuslikis BI, Fink GD.
    J Cardiovasc Pharmacol; 1987 Mar 16; 9(3):298-304. PubMed ID: 2437396
    [Abstract] [Full Text] [Related]

  • 14. Brain angiotensin: critical role in the ongoing regulation of body fluid homeostasis and cardiovascular function.
    Harding JW, Jensen LL, Quirk WS, Dewey AL, Wright JW.
    Peptides; 1989 Mar 16; 10(2):261-4. PubMed ID: 2755868
    [Abstract] [Full Text] [Related]

  • 15. Hypotensive effects of sarthran in normotensive and spontaneously hypertensive rat strains.
    Murray CE, Harding JW, Wright JW.
    Pharmacol Biochem Behav; 1991 Aug 16; 39(4):1029-32. PubMed ID: 1763099
    [Abstract] [Full Text] [Related]

  • 16. Peptidase inhibitor-induced antidiuresis mediated through angiotensin and opioid receptors in the rat hypothalamus.
    Tsushima H, Mori M, Matsuda T.
    Jpn J Pharmacol; 1996 May 16; 71(1):61-71. PubMed ID: 8791172
    [Abstract] [Full Text] [Related]

  • 17. Structure-function analyses of brain angiotensin control of pressor action in rats.
    Wright JW, Jensen LL, Roberts KA, Sardinia MF, Harding JW.
    Am J Physiol; 1989 Dec 16; 257(6 Pt 2):R1551-7. PubMed ID: 2604011
    [Abstract] [Full Text] [Related]

  • 18. Cochlear blood flow autoregulation in Wistar-Kyoto rats.
    Quirk WS, Dengerink HA, Coleman JK, Wright JW.
    Hear Res; 1989 Aug 16; 41(1):53-60. PubMed ID: 2793614
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological profile of depressor response elicited by sarthran in rat ventrolateral medulla.
    Ito S, Sved AF.
    Am J Physiol Heart Circ Physiol; 2000 Dec 16; 279(6):H2961-6. PubMed ID: 11087253
    [Abstract] [Full Text] [Related]

  • 20. Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins.
    Ahmad S, Ward PE.
    J Pharmacol Exp Ther; 1990 Feb 16; 252(2):643-50. PubMed ID: 1968973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.